Paratek Pharmaceuticals, Inc. | Uncategorized | Business Contracts

Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended (Filed With SEC on March 14, 2022)

Amendment No. 4 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of November 17, 2021 (Filed With SEC on March 14, 2022)

Amendment No. 2 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of June 1, 2019 (Filed With SEC on January 4, 2021)

Amendment No. 3 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of July 1, 2020 (Filed With SEC on January 4, 2021)

Description of Securities (Filed With SEC on March 10, 2020)

Amended and Restated Employee Agreement for Michael F. Bigham effective June 25, 2019 (Filed With SEC on August 6, 2019)

Amended and Restated Employee Agreement for Evan Loh, MD, effective June 25, 2019 (Filed With SEC on August 6, 2019)

Amended and Restated Employee Agreement for Adam Woodrow effective June 25, 2019 (Filed With SEC on August 6, 2019)

Amendment Agreement - Amendment No. 1 to Patheon Product Agreement by and between the Company and Patheon UK Limited dated as of January 1, 2019 (Filed With SEC on May 8, 2019)

First Amendment of Outsourcing Agreement, by and between the Company and CARBOGEN AMCIS AG, dated as of December 18, 2018 (Filed With SEC on March 6, 2019)

Paratek Pharmaceuticals, Inc. (34) | Uncategorized (10)